⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

April 18, 2023Leukemia & lymphoma/Leukemia and lymphoma

Administration of glucocorticoids prior to liquid biopsy dramatically reduces the detection rate of MYD88 L265P mutation in cerebrospinal fluid of primary CNS lymphoma patients

Haruhiko Takahashi Manabu Natsumeda Jotaro On Jun Watanabe Mari Tada Hiroshi Shimizu Yoshihiro Tsukamoto Masayasu Okada Makoto Oishi Jun Takizawa Yasuhiko Hayashi Yasufumi Masaki Akiyoshi Kakita Yukihiko Fujii

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

We [1,2] and others [3,4] have reported the usefulness of liquid biopsy to diagnose primary central nervous system lymphomas (PCNSL) by detecting cell free circulating tumor DNA (cctDNA) in cerebro...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Takahashi et al. (2023) studied this question.

synapsesocial.com/papers/6a9d69a69675ea02512a0353 https://doi.org/10.1080/10428194.2023.2199895

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Projected population size by treatment line in diffuse large B-cell lymphoma in the United States, 2024–2028Leukemia & lymphoma/Leukemia and lymphoma · 2026
2Perniosis-like lesions as an extramedullary manifestation preceding a chronic myelomonocytic leukemia diagnosis: a clinicopathological and molecular descriptionLeukemia & lymphoma/Leukemia and lymphoma · 2026
3Patient empowerment in Hodgkin Lymphoma (HL) through continuously accessible information resourcesLeukemia & lymphoma/Leukemia and lymphoma · 2026
4Outpatient venetoclax initiation following obinutuzumab debulking in patients with high or medium tumor burden at baselineLeukemia & lymphoma/Leukemia and lymphoma · 2026
5Primary CNS lymphoma mimicking brain metastases with successful glucarpidase rescue and methotrexate rechallengeLeukemia & lymphoma/Leukemia and lymphoma · 2026
6First-line pemigatinib in a myeloid/lymphoid neoplasm with FGFR1 rearrangement: shifting the current treatment paradigmLeukemia & lymphoma/Leukemia and lymphoma · 2026
7The APLC 2025 consensus recommendations on the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemiaLeukemia & lymphoma/Leukemia and lymphoma · 2026
8Lower baseline eosinophil counts are associated with inferior survival in Mantle cell lymphomaLeukemia & lymphoma/Leukemia and lymphoma · 2026
9Single-Cell RNA sequencing analysis of cellular heterogeneity and microenvironment-driven signaling networks in acute myeloid leukemiaLeukemia & lymphoma/Leukemia and lymphoma · 2026
10Chronic myelomonocytic leukemia associated with lymphoid neoplasmsLeukemia & lymphoma/Leukemia and lymphoma · 2026

More from Leukemia & lymphoma/Leukemia and lymphoma

More from Niigata University

More from Kanazawa Medical University